About Agile Therapeutics
Agile Therapeutics is a company based in Princeton (United States) founded in 1997 was acquired by Insud Pharma in August 2024. It operates as a HealthTech. Agile Therapeutics has raised $124.07 million across 12 funding rounds from investors including Investor, Insud Pharma and National Science Foundation. Agile Therapeutics offers products and services including Twirla. Agile Therapeutics operates in a competitive market with competitors including Auxilium Pharmaceuticals, Marius Pharmaceuticals, Peptonic Medical, Microchips Biotech and Asarina Pharma, among others.
- Headquarter Princeton, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Agile Therapeutics, Inc.
-
Annual Revenue
$19.59 M80as on Dec 31, 2023
-
Net Profit
$-14.47 M43as on Dec 31, 2023
-
EBITDA
$-19.88 M62as on Dec 31, 2023
-
Total Equity Funding
$124.07 M (USD)
in 12 rounds
-
Latest Funding Round
$275 K (USD), Grant
Feb 01, 2024
-
Investors
Investor
& 8 more
-
Employee Count
Employee Count
-
Acquired by
Insud Pharma
(Aug 26, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Agile Therapeutics
Agile Therapeutics offers a comprehensive portfolio of products and services, including Twirla. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Twirla is developed for women's contraceptive healthcare needs.
Unlock access to complete
Funding Insights of Agile Therapeutics
Agile Therapeutics has successfully raised a total of $124.07M across 12 strategic funding rounds. The most recent funding activity was a Grant round of $275 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Grant — $275,000
-
First Round
First Round
(28 Oct 2009)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Grant - Agile Therapeutics | Valuation |
investors |
|
| Mar, 2019 | Amount | Post-IPO - Agile Therapeutics | Valuation |
investors |
|
| Dec, 2015 | Amount | Grant - Agile Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Agile Therapeutics
Agile Therapeutics has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Investor, Insud Pharma and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investments are directed by the Wallenberg family into Nordic sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Agile Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Agile Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Agile Therapeutics Comparisons
Competitors of Agile Therapeutics
Agile Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Auxilium Pharmaceuticals, Marius Pharmaceuticals, Peptonic Medical, Microchips Biotech and Asarina Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutics and drug-device combinations for urology and sexual health
|
|
| domain | founded_year | HQ Location |
A proprietary oral testosterone replacement therapy platform is developed.
|
|
| domain | founded_year | HQ Location |
Estrogen-free treatment for vaginal atrophy is developed using natural oxytocin.
|
|
| domain | founded_year | HQ Location |
Microchip implants for wireless drug delivery are developed.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals for PMDD, migraine, and Tourette syndrome are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Agile Therapeutics
Frequently Asked Questions about Agile Therapeutics
When was Agile Therapeutics founded?
Agile Therapeutics was founded in 1997 and raised its 1st funding round 12 years after it was founded.
Where is Agile Therapeutics located?
Agile Therapeutics is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Who is the current CEO of Agile Therapeutics?
Al Altomari is the current CEO of Agile Therapeutics.
Is Agile Therapeutics a funded company?
Agile Therapeutics is a funded company, having raised a total of $124.07M across 12 funding rounds to date. The company's 1st funding round was a Grant of $6M, raised on Oct 28, 2009.
What is the annual revenue of Agile Therapeutics?
Annual revenue of Agile Therapeutics is $19.59M as on Dec 31, 2023.
What does Agile Therapeutics do?
Agile Therapeutics is dedicated to providing innovative healthcare solutions for women. The company specializes in pharmaceutical products using proprietary SkinFusion Technology. Their primary product, Twirla, is designed to address contraceptive needs. Commitment to environmental, social, and governance (ESG) principles is emphasized. Partnerships and research are leveraged to expand product pipelines. The focus remains on enhancing womens healthcare choices across various platforms.
Who are the top competitors of Agile Therapeutics?
Agile Therapeutics's top competitors include Auxilium Pharmaceuticals, Theramex and Marius Pharmaceuticals.
What products or services does Agile Therapeutics offer?
Agile Therapeutics offers Twirla.
Who are Agile Therapeutics's investors?
Agile Therapeutics has 9 investors. Key investors include Investor, Insud Pharma, National Science Foundation, Aisling Capital, and Care Capital.